BMC Cancer · 2020 · 47 citations · 26 references
MedicineOncologyPathologyMolecular OncologyNeoplasiaTumor PathologyCancer StagingImmunohistochemistryLung CancerMalignant NeoplasmsSquamous Cell CarcinomaTumor StagingClinicopathologic FeaturesImmunohistochemical BiomarkersImmunohistochemical MarkersImmunohistochemical StainingLung AdenocarcinomaLung Cancer StagingSpread Through Air SpacesVimentin Expression
BACKGROUND: This study aimed to comprehensively investigate the effect of spread through air spaces (STAS) on clinicopathologic features, molecular characteristics, immunohistochemical expression, and prognosis in lung adenocarcinomas (ADC) and squamous cell carcinomas (SQCC) based on the 8th edition AJCC/UICC staging system. METHODS: In total, 303 ADC and 121 SQCC cases were assessed retrospectively. Immunohistochemical staining was performed for E-cadherin, vimentin, Ki67, survivin, Bcl-2, and Bim. Correlations between STAS and other parameters were analyzed statistically. RESULTS: STAS was observed in 183 (60.4%) ADC and 39 (32.2%) SQCC cases. In ADC, the presence of STAS was associated with wild-type EGFR, ALK and ROS1 rearrangements, low E-cadherin expression, and high vimentin and Ki67 expression. In SQCC, STAS was associated with low E-cadherin expression and high vimentin and survivin expression. Based on univariate analysis, STAS was associated with significantly shorter disease-free survival (DFS) and overall survival (OS) in ADC. In SQCC, STAS tended to be associated with shorter OS. By multivariate analysis, STAS was an independent poor prognostic factor in ADC for DFS but not OS. Stratified analysis showed that STAS was correlated with shorter DFS for stage I, II, IA, IB, and IIA ADC based on univariate analysis and was an independent risk factor for DFS in stage I ADC cases based on multivariate analysis. CONCLUSIONS: Our findings revealed that STAS is an independent negative prognostic factor for stage I ADC using the new 8th edition AJCC/UICC staging system. Stage I patients with STAS should be followed up more closely and might need different treatment strategies.
26
Ramón Rami–Porta, Vanessa Bolejack, John Crowley et al. · Journal of Thoracic Oncology · 2015 · 774 citations · Full text
Kyuichi Kadota, Jun‐ichi Nitadori, Camelia S. Sima et al. · Journal of Thoracic Oncology · 2015 · 674 citations · Full text
Takashi Eguchi, Koji Kameda, Shaohua Lu et al. · Journal of Thoracic Oncology · 2018 · 289 citations